A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

Dr. Oz once asked the question on his titular talk show, “Could a diabetes drug cure obesity?” He was referring to ...

Grappling with obesity and the metabolic diseases cascading from it, they are now among the plurality of Americans who have ...

Compounded semaglutide has emerged as a significant development in the management of obesity and type 2 diabetes. As a ...

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Researchers used real-world data to identify key factors for long-term weight loss for patients taking GLP-1 drugs like Ozempic and Wegovy.

Researchers in France have developed a once-a-month hydrogel-based delivery system for semaglutide, significantly simplifying ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

MADRID — The benefits of semaglutide treatment in reducing kidney disease, cardiovascular, and mortality risks in people with ...

Some plans include clinical options like prescription drugs. Over the years, options like Semaglutide and Tirzepatide have ...